1 min read
Lakefront Biotherapeutics Starts New €50 Million Share Buyback
The authorization took effect Nov. 16 and runs through no later than March 31, 2027. The prior €50 million program ended Oct. 16 after repurchasing about 1.99 million ordinary shares.

Lakefront Biotherapeutics NV (LKFT) began a new €50 million share repurchase authorization Nov. 16, with purchases allowed through no later than March 31, 2027, after its previous program ended.
The company completed its earlier €50 million buyback Oct. 16. That program repurchased about 1.99 million ordinary shares.